Bilirubin and beyond: A review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protectionBulmer, A. C., Verkade, H. J. & Wagner, K. -H., Apr-2013, In : Progress in lipid research. 52, 2, p. 193-205 13 p.
Research output: Contribution to journal › Review article › Academic › peer-review
Gilbert's syndrome (GS) is characterized by a benign, mildly elevated bilirubin concentration in the blood. Recent reports show clear protection from cardiovascular disease in this population. Protection of lipids, proteins and other macromolecules from oxidation by bilirubin represents the most commonly accepted mechanism contributing to protection in this group. However, a recent meta-analysis estimated that bilirubin only accounts for similar to 34% of the cardioprotective effects within analysed studies. To reveal the additional contributing variables we have explored circulating cholesterol and triacylglycerol concentrations, which appear to be decreased in hyperbilirubinemic individuals/animals, and are accompanied by lower body mass index in highly powered studies. These results suggest that bilirubin could be responsible for the development of a lean and hypolipidemic state in GS. Here we also discuss the possible contributing mechanisms that might reduce circulating cholesterol and triacylglycerol concentrations in individuals with syndromes affecting bilirubin metabolism/excretion, which we hope will stimulate future research in the area. In summary, this article is the first review of lipid status in animal and human studies of hyperbilirubinemia and explores possible mechanisms that could contribute to lowering circulating lipid parameters and further explain cardiovascular protection in Gilbert's syndrome. (C) 2012 Published by Elsevier Ltd.
|Number of pages||13|
|Journal||Progress in lipid research|
|Publication status||Published - Apr-2013|
- Aryl hydrocarbon receptor, Cholesterol, Triacylglycerol, Bile pigment, Phosopholipid, Crigler-Najjar syndrome, Gunn rat, Obesity, Heme oxygenase, ARYL-HYDROCARBON RECEPTOR, CRIGLER-NAJJAR-SYNDROME, ISCHEMIC-HEART-DISEASE, ORGANIC-ANIONS AFFECTS, 14 RANDOMIZED-TRIALS, SERUM BILIRUBIN, GUNN RAT, UNCONJUGATED HYPERBILIRUBINEMIA, OXIDATIVE STRESS, AH RECEPTOR